A phase‐1 study of sequential mitomycin C and 5–aminolaevulinic acid‐mediated photodynamic therapy in recurrent superficial bladder carcinoma
- 12 May 2005
- journal article
- clinical trial
- Published by Wiley in BJU International
- Vol. 95 (9), 1206-1210
- https://doi.org/10.1111/j.1464-410x.2005.05506.x
Abstract
To report a phase-1 study of patients with recurrent superficial bladder cancer treated with photodynamic therapy (PDT) using sequential mitomycin C and 5-aminolaevulinic acid (ALA). Twenty-four patients were treated, the primary endpoint being the safety and tolerability of combined therapy at increasing doses of ALA and light. Mitomycin C instillation was followed by ALA concentrations of 6%, 8% or 10%; there was no effect on toxicity. The light dose, at a wavelength of 635 nm, was increased from zero to 25 J/cm(2), with the upper fluences producing transient symptoms. There were no episodes of skin photosensitivity or systemic toxicity. A total fluence of 25 J/cm(2) represented the upper light dose for the tolerability of this procedure by patients. There were no persistently high urinary symptom scores or reduction in functional bladder capacity up to > or =24 months of follow-up. In this group, cumulative tumour recurrences were none at 4, two at 8, six at 12, nine at 18 and 11 at 24 months after PDT, respectively. Sequential mitomycin C and ALA-PDT is a safe and well tolerated treatment, with potential for managing difficult-to-control superficial transitional cell carcinoma and carcinoma in situ of the bladder.Keywords
This publication has 25 references indexed in Scilit:
- Comparison of Aminolevulinic Acid and Hexylester Aminolevulinate Induced Protoporphyrin IX Distribution in Human Bladder CancerJournal of Urology, 2003
- Wavelength Dependent Photodynamic Effects on Chemically Induced Rat Bladder Tumors Following Intravesical Instillation of 5-Aminolevulinic AcidJournal of Urology, 1997
- Wavelength Dependent Photodynamic Effects on Chemically Induced Rat Bladder Tumors Following Intravesical Instillation of 5-Aminolevulinic AcidJournal of Urology, 1997
- Electromotive diffusion (EMD) and photodynamic therapy with δ-aminolaevulinic acid (δ-ALA) for superficial bladder cancerJournal of Photochemistry and Photobiology B: Biology, 1996
- Biodistribution of Protoporphyrin IX in Rat Urinary Bladder after Intravesical Instillation of 5-Aminolevulinic AcidJournal of Urology, 1996
- Early clinical experience with 5‐aminolevulinic acid for the photodynamic therapy of superficial bladder cancerBritish Journal of Urology, 1996
- Biodistribution of Protoporphyrin IX in Rat Urinary Bladder after Intravesical Instillation of 5-Aminolevulinic AcidJournal of Urology, 1996
- Enhancement of interstitial photodynamic therapy by mitomycin C and EO9 in a mouse tumour modelInternational Journal of Cancer, 1994
- The use of photodynamic therapy (PDT) for the treatment of superficial tumours on the bladder wallLasers in Medical Science, 1990